Research programme: diagnostic imaging - ART Advanced Research Technologies
Alternative Names: MP 510; MP 610Latest Information Update: 16 Jul 2016
Price :
$50 *
At a glance
- Originator ART Advanced Research Technologies
- Class Imaging agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Vascular disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer(Diagnosis) in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in Vascular-disorders(Diagnosis) in USA
- 14 Mar 2006 Alerion Biomedical has been acquired by ART Advanced Research Technologies